Evidence map›Paper›PMID 36528474›Full record

ArticleClinical oncology (Royal College of Radiologists (Great Britain))2023

The Impact of COVID-19 on Radiotherapy Services in Scotland, UK: A Population-based Study.

L Grocutt, A Rutherford, D Caldwell, C Wilkinson, A J Chalmers, L Dempsey, C Kelly, S M O'Cathail

Open access · hybridAbstract read
In one paragraph

Article in Clinical oncology (Royal College of Radiologists (Great Britain)), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. [Incidence of COVID-19 in cancer patients from the HIGA Alende, Mar del Plata, Argentina, 2020-2021]Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

L GrocuttCRUK RadNet Glasgow, University of Glasgow, Glasgow, UK; Department of Radiotherapy Physics, The Beatson West of Scotland Cancer Centre, Glasgow, UK. Electronic address: laura.grocutt@glasgow.ac.uk.
A RutherfordDepartment of Radiotherapy Physics, The Beatson West of Scotland Cancer Centre, Glasgow, UK.
D CaldwellNRS CRN-W, Radiotherapy Department, The Beatson West of Scotland Cancer Centre, Glasgow, UK.
C WilkinsonNRS CRN-W, Radiotherapy Department, The Beatson West of Scotland Cancer Centre, Glasgow, UK.
A J ChalmersInstitute of Cancer Sciences, University of Glasgow, Glasgow, UK.
L DempseyCancer Research UK Glasgow Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
C KellyCancer Research UK Glasgow Clinical Trials Unit, The Beatson West of Scotland Cancer Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.
S M O'CathailInstitute of Cancer Sciences, University of Glasgow, Glasgow, UK.
University of Glasgow · GBBeatson West of Scotland Cancer Centre · GB

Funding

Cancer Research UK 25355Cancer Research UK 28803Cancer Research UK C16583/A28803Cancer Research UK C7932/A25142
6 · The paper itself

Abstract

aimsThe effect of the COVID-19 pandemic on cancer radiotherapy services is largely unknown. The aim of the present study was to investigate the impact of the resultant contingency plans on radiotherapy cancer services in Scotland. MATERIALS AND

methodsDetailed data of radiotherapy activity at our centre were collected from 1 April 2019 to 31 March 2021. Differences in mean weekly radiotherapy courses, dose and fractionation patterns and treatment intent were compared with corresponding pre-pandemic months for all treatment sites. Qualitative data were collected for a subgroup of radical radiotherapy patients.

resultsTotal radiotherapy courses decreased from 6968 to 6240 (-10%) compared with the previous year, prior to the pandemic. Average weekly radiotherapy courses delivered were 134 (standard deviation ±13), decreasing by 10% to 120 (standard deviation 15) (Welch's t-test, P < 0.001). The greatest decrease in new start treatment courses was observed from May to August 2020 (-7.7%, -24.0%, -16.7% and -18.7%) compared with the corresponding months in 2019. A significant reduction was seen for female patients <70 years (-16%) compared with females >70 years (-8%) or their male counterparts (-7% and -6%, respectively). By diagnosis, the largest reductions between pre- and post-pandemic levels were for anal (-26%), breast (-18%) and prostate (-14%) cancer. Contrarily, a significant increase was found for bladder (28%) and oesophageal (11%) cancers.

conclusionsOver the first 12 months of the COVID-19 pandemic, radiotherapy activity significantly decreased compared with the 12 months prior. Due to issued guidance, the use of hypofractionated regimens increased, contributing to the reduction in treatments for some tumour sites. An increase in other tumour sites can probably be attributed to the reduction or cancellation of surgical interventions. These results will inform our understanding of the indirect consequences of the pandemic on radiotherapy services.

Indexed as

COVID-19NeoplasmsDose Fractionation, RadiationFemaleHumansMalePandemicsScotlandCOVID-19pandemicradiotherapySARS-CoV-2ScotlandUK

Identifiers

PMID36528474
PMCPMC9708615
OpenAlexW4311768795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.